Skip to main content
Premium Trial:

Request an Annual Quote

Nihon Gene Research Lab to Use CombiMatrix Biochip Synthesizer for Services Business

NEW YORK, April 7 - CombiMatrix, a subsidiary of Acacia Research, said today that it has sold a DNA Microarray Synthesizer to Nihon Gene Research Laboratory (NGRL) in Sendai, Japan.


NGRL plans to use the synthesizer as part of a custom microarray production and analysis service for the Japanese research and drug discovery market.


NGRL purchased a CombiMatrix custom slide biochip synthesizer and also entered a multi-year agreement to purchase additional biochips for its contract research services business.


CombiMatrix and NGRL have also entered a co-development and research agreement to "investigate various aspects of genetic analysis." Further details were not provided.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.